Showing results (131-140 of 211) with videos related to

Sort By:
Pageof 22
American Journal of Clinical Pathology|September 19, 2013
CD90 is a diagnostic marker to differentiate between malignant pleural mesothelioma and lung carcinoma with immunohistochemistryKiyoko Kawamura, Kenzo Hiroshima, Takeo Suzuki, et al.
Experimental Cell Research|January 29, 2019
Growth suppression of human oral cancer cells by candidate agents for cetuximab-side effectsKatsuhiro Uzawa, Atsushi Kasamatsu, Tomoaki Saito, et al.
Oncology Letters|June 5, 2023
Sequential administration of PD‑1 inhibitor and cetuximab causes pneumoniaMakoto Arai, Mitsuhiro Abe, Shinsuke Kitahara, et al.
Oncology Reports|December 4, 2009
State of homeobox A10 expression as a putative prognostic marker for oral squamous cell carcinomaMasanobu Yamatoji, Atsushi Kasamatsu, Yukio Yamano, et al.
Cancer Gene Therapy|May 28, 2003
T-cell-dependent antitumor effects produced by CD40 ligand expressed on mouse lung carcinoma cells are linked with the maturation of dendritic cells and secretion of a variety of cytokinesYuji Tada, Jiyang O-Wang, Ling Yu, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 22, 2008
Gender differences in chronic thromboembolic pulmonary hypertension in JapanAyako Shigeta, Nobuhiro Tanabe, Hidefumi Shimizu, et al.
Japanese Journal of Clinical Oncology|May 10, 2019
Phase II trial of S-1 plus cisplatin combined with bevacizumab for advanced non-squamous non-small cell lung cancer (TCOG LC-1202)Akihiko Miyanaga, Kaoru Kubota, Yukio Hosomi, et al.
Investigational New Drugs|April 11, 2022
Practical consideration for successful sequential tumor biopsies in first-in-human trialsTakafumi Koyama, Toshio Shimizu, Jun Sato, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 17, 2022
[Maturation and Development of the"All Japan E-Learning Cloud of the Training Program for Oncology Professionals]Jaejeong Kim, Yohei Owada, Kosuke Kojo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 26, 2010
Long-term administration of second-line chemotherapy with S-1 and gemcitabine for platinum-resistant non-small cell lung cancer: a phase II studyYuichi Takiguchi, Takashi Seto, Yukito Ichinose, et al.
Pageof 22